Eaton Vance Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-217	Closed	-$8K	–	1845
2021 Q4	$8K	Sell	217 -8	-4%	-$320	﹤0.01%	2566
2021 Q3	$0	Sell	225 -109	-33%	-$4.49K	﹤0.01%	2015
2021 Q2	$15K	Buy	334 +269	+414%	+$11.5K	﹤0.01%	2476
2021 Q1	$3K	Sell	65 -5,290	-99%	-$201K	﹤0.01%	2688
2020 Q4	$242K	Buy	+5,355	New	+$203K	﹤0.01%	1378
2018 Q4	–	Sell	-5,732	Closed	-$242K	–	1176
2018 Q3	$242K	Buy	+5,732	New	+$226K	﹤0.01%	1154
2018 Q2	–	Sell	-11,464	Closed	-$570K	–	1173
2018 Q1	$570K	Buy	11,464 +5,732	+100%	+$324K	﹤0.01%	1073
2017 Q4	$309K	Buy	5,732 +4	+0.1%	+$221	﹤0.01%	1046
2017 Q3	$332K	Buy	5,728 +2	+0%	+$105	﹤0.01%	1012
2017 Q2	$283K	Buy	5,726 +8	+0.1%	+$368	﹤0.01%	1015
2017 Q1	$248K	Sell	5,718 -295	-5%	-$14.1K	﹤0.01%	993
2016 Q4	$294K	Hold	6,013	–	–	﹤0.01%	941
2016 Q3	$288K	Hold	6,013	–	–	﹤0.01%	920
2016 Q2	$323K	Sell	6,013 -2,000	-25%	-$94.2K	﹤0.01%	878
2016 Q1	$358K	Hold	8,013	–	–	﹤0.01%	842
2015 Q4	$306K	Sell	8,013 -2,002	-20%	-$76.6K	﹤0.01%	868
2015 Q3	$319K	Hold	10,015	–	–	﹤0.01%	852
2015 Q2	$331K	Hold	10,015	–	–	﹤0.01%	828
2015 Q1	$412K	Buy	+10,015	New	+$405K	﹤0.01%	825